Verified Nov 2026
Other
·
Ljubljana, Ljubljana
·
Since
Lek Pharmaceuticals, headquartered in Ljubljana, Slovenia, is a Sandoz company founded in 1946 and employs 1,000–5,000 staff. The company develops, manufactures, and markets generic medicines, biosimilars, and active pharmaceutical ingredients for healthcare systems and patients across nearly 60 markets. Recent expansion includes a new high-tech biosimilar production facility opened in Lendava in 2026.
Lek Pharmaceuticals at a glance
Revenue
$1-5B
Est. band
Employees
1,000-5,000
Headquarters
Ljubljana, Ljubljana
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Lek Pharmaceuticals, headquartered in Ljubljana, Slovenia, is a Sandoz company founded in 1946 and employs 1,000–5,000 staff. The company develops, manufactures, and markets generic medicines, biosimilars, and active pharmaceutical ingredients for healthcare systems and patients across nearly 60 markets. Recent expansion includes a new high-tech biosimilar production facility opened in Lendava in 2026.
At a glance
Attribute | Detail |
|---|---|
Headquarters | Ljubljana, Ljubljana |
Employees | 1,000-5,000 |
Revenue | $1-5B (estimated) |
What Lek Pharmaceuticals makes
The company produces generic medicines, biosimilars, and active pharmaceutical ingredients across multiple production sites, serving as biosimilar provider in Slovenia.
Latest developments
2026-09-29 — Sandoz opens new high-tech biosimilar centre in Lendava | Lek (lek.si)
2026-09-08 — Sandoz expands biosimilars manufacturing in Ljubljana | Lek (lek.si)
2026-08-19 — 330 novih mest v Lendavi in 267 na Brniku, Lekov naložbeni cikel se izteka letos | Lider.si (lider.si)
2026-06-17 — Sandoz opens state-of-the-art biosimilar development centre in Slovenia | Lek (lek.si)
2026-06-05 — Lek investira milijardo evrov v tri nove proizvodne centre (finance.si)
2025-08-10 — EU supported high tech lab for medicines quality | Lek (lek.si)
Company details
Lek operates as a major development and manufacturing hub within the global Sandoz group and holds a significant market position in generic and biosimilar pharmaceuticals across European and international markets. Lek Pharmaceuticals has an estimated 1,000-5,000 employees, and is headquartered in Ljubljana, Ljubljana.
Frequently asked questions
What does Lek Pharmaceuticals do?
Lek Pharmaceuticals, headquartered in Ljubljana, Slovenia, is a Sandoz company founded in 1946 and employs 1,000–5,000 staff. The company develops, manufactures, and markets generic medicines, biosimilars, and active pharmaceutical ingredients for healthcare systems and patients across nearly 60 markets. Recent expansion includes a new high-tech biosimilar production facility opened in Lendava in 2026.
Where is Lek Pharmaceuticals headquartered?
Lek Pharmaceuticals is headquartered in Ljubljana, Ljubljana.
How big is Lek Pharmaceuticals?
Lek Pharmaceuticals has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
